The FDA’s recent COVID-19 vaccine update approvals that target older adults and high-risk individuals are raising concerns that limiting access for other populations could leave millions of otherwise healthy or moderately at-risk people exposed to infection, hospitalization, long COVID and other complications.

Jennifer Walsh, DNP, CPNP, CNE, assistant professor at George Washington University School of Nursing, told Managed Healthcare Executive that restricting vaccine eligibility will impact the availability and uptake of vaccinations, “exposing more people to infection, hospitalization, risk of long-COVID and risk of death.”

She expressed that insurance coverage and programs such as Vaccines for Children (VFC) may not extend to those outside the recommended groups, disproportionately

See Full Page